Intercept Pharmaceuticals reported $12.59M in Interest Expense on Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Alnylam Pharmaceuticals ALNY:US $ 33.42M 901K
Amarin AMRN:US $ 0.03M 0.02M
Amgen AMGN:US $ 281M 4M
Arena Pharmaceuticals ARNA:US $ 1.05M 0.02M
Biogen BIIB:US $ 56.4M 8.3M
Bristol Myers Squibb BMY:US $ 330M 23M
Eli Lilly And LLY:US $ 86.9M 0.9M
Esperion Therapeutics ESPR:US $ 11.14M 3.02M
Galectin Therapeutics GALT:US $ 85K 63K
Gilead Sciences GILD:US $ 256M 1M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
IONIS PHARMACEUT IONS:US $ 2.36M 0.06M
Moderna Inc MRNA:US 5M 2M
Neurocrine Biosciences NBIX:US $ 6.2M 0.2M
Novartis NOVN:VX 201M 1000K
Ptc Therapeutics PTCT:US $ 22.56M 2.7M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Sarepta Therapeutics SRPT:US $ 15.83M 0.18M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M
YTE INCY:US $ 0.36M 0M